You are here

Vanda Pharmaceuticals to Announce First Quarter 2019 Financial Results on May 1, 2019

WASHINGTON, April 18, 2019 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced it will release results for the first quarter 2019 on Wednesday, May 1, 2019, after the market closes.  

Vanda will host a conference call at 4:30 PM ET on Wednesday, May 1, 2019, during which management will discuss the first quarter 2019 financial results and other corporate activities. To participate in the conference call, please dial 1-866-688-9426 (domestic) or 1-409-216-0816 (international) and use passcode 6195579.

The conference call will be broadcast simultaneously and archived on Vanda's website, www.vandapharma.com. Investors should go to the website at least 15 minutes early to register, download, and install any necessary audio software.

A replay of the call will be available on Wednesday, May 1, 2019, beginning at 7:30 PM ET and will be accessible until Wednesday, May 8, 2019, at 11:59 PM ET. The replay call-in number is 1-855-859-2056 for domestic callers and 1-404-537-3406 for international callers.  The passcode number is 6195579.

ABOUT VANDA PHARMACEUTICALS INC.:
Vanda is a global biopharmaceutical company focused on the development and commercialization of innovative therapies to address high unmet medical needs and improve the lives of patients. For more on Vanda Pharmaceuticals Inc., please visit www.vandapharma.com.

Investor Contact:
Jim Kelly
Executive Vice President & Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com 

Cision View original content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-to-announce-first-quarter-2019-financial-results-on-may-1-2019-300834885.html

SOURCE Vanda Pharmaceuticals Inc.